Brent Morse is a highly educated professional with a background in Medicinal Chemistry & Molecular Pharmacology, holding an MS from Purdue University and a BS in Chemistry from Western Michigan University.

With an extensive career in the biopharmaceutical industry, Brent Morse currently serves as the Head of Process and Analytical Development at Vor Biopharma. Prior to this role, he held leadership positions at prominent companies including CRISPR Therapeutics, EPIRUS Biopharmaceuticals, AbbVie, Concert Pharmaceuticals, Inc., Adnexus Therapeutics, Gmp Genetics, and Antigenics.

His expertise spans from late-stage analytical development to bioanalytical development, molecular and cellular pharmacology, biology, pharmacology, and staff scientist roles. Brent Morse's diverse experience demonstrates his proficiency in various aspects of pharmaceutical research and development.